- Published on
Infectious Disease and Microbiology – Actinomycosis
Actinomycosis is a chronic, slowly progressive, suppurative, and tissue-destructive infection characterized by mass-like lesions and sinus tract formation. It most commonly affects the head and neck region but may also involve the thorax, abdomen, pelvis, central nervous system, bones, and soft tissues. The disease is indolent and often mimics malignancy or other chronic infections.
The reported incidence is approximately 1 per 300,000 population in the United States and about 1 per 100,000 in Europe. It occurs at all ages, with peak frequency in middle-aged adults, and has a male-to-female ratio of about 3:1. Risk factors include poor oral hygiene, dental manipulation, oral trauma, intrauterine contraceptive device (especially when used for more than 2 years), abdominal surgery, appendicitis, diverticulitis, foreign bodies, malnutrition, and immunodeficiency such as HIV infection, chronic granulomatous disease, or prolonged corticosteroid therapy. Cases have also been described in osteoradionecrosis and bisphosphonate-related mandibular osteonecrosis. Prevention includes maintaining good oral hygiene and, in women with long-term intrauterine devices and suspicious symptoms, device removal with short-term antibiotic therapy. Patient isolation is not required.
Humans are the natural reservoir. The organisms colonize the oral cavity, particularly dental plaque and tonsillar crypts, as commensals. Infection typically follows disruption of the mucosal barrier due to trauma or surgery, allowing invasion into deeper tissues. The disease spreads contiguously and occasionally hematogenously. Aspiration may lead to thoracic involvement, while abdominal and pelvic disease often follows bowel perforation, appendicitis, or diverticulitis. Although incubation is unclear, diagnosis is usually delayed because of the chronic course. Clinical forms include cervicofacial, thoracic, abdominal, pelvic, central nervous system, and disseminated disease.
Actinomyces species are microaerophilic or anaerobic, filamentous, branched, Gram-positive, non–acid-fast rods. Actinomyces israelii is the most frequently identified species, although A. naeslundii, A. meyeri, A. odontolyticus, and Propionibacterium propionica have also been implicated. These organisms are normal flora of the oral cavity and female genital tract. Most infections are polymicrobial, often involving anaerobic oral flora that may act as copathogens.
Clinical presentation varies by site. Patients may have low-grade fever, weight loss, and pain. Cervicofacial disease often presents with perimandibular swelling, trismus, and purplish discoloration of overlying skin, with sinus tract formation draining characteristic yellow “sulfur granules.” Thoracic disease presents with cough, chest pain, dyspnea, mass-like lesions, pleural thickening, empyema, chest wall invasion, and possible mediastinal or spinal involvement. Abdominal disease typically manifests as a firm mass, often in the right iliac fossa following appendicitis, or in the left lower quadrant after diverticulitis, sometimes with chronic perianal abscesses and fistulae. Pelvic disease may present as abscesses or a “frozen pelvis.” Central nervous system involvement causes focal neurologic deficits or chronic meningitis.
Diagnosis requires high suspicion, especially when mass lesions coexist with draining sinuses and sulfur granules. Specimens should be obtained before antibiotic therapy. Gram stain of pus or tissue from sterile sites demonstrating filamentous, Gram-positive, non–acid-fast organisms is more sensitive than culture. Swab cultures are not recommended, and specimens must be processed anaerobically. Direct immunofluorescence may assist in specific cases. Imaging with CT or MRI helps determine disease extent. Lung disease may show the “open bronchus sign.” Bone involvement may demonstrate a saw-toothed appearance, and CNS disease often appears as single or multiloculated lesions with surrounding edema. Differential diagnosis includes malignancy, nocardiosis, tuberculosis, botryomycosis, and endemic fungal infections.
Treatment consists of prolonged high-dose penicillin therapy. Recommended first-line therapy includes intravenous penicillin G (10–24 million units daily in divided doses) for 2–6 weeks, followed by oral penicillin V for 6–12 months, or intravenous ampicillin followed by oral amoxicillin for similar duration. Mild cervicofacial disease may be treated with oral therapy alone. Alternatives for penicillin-allergic patients include tetracyclines, erythromycin, or clindamycin. Surgical intervention, including abscess drainage or excision of fibrotic tissue, is often necessary.
Prognosis is generally excellent with appropriate prolonged therapy, as resistance among Actinomyces species is rare. Treatment failure usually suggests an undrained abscess or presence of resistant copathogens. Potential complications include disseminated disease and bowel obstruction in extensive abdominal or pelvic involvement.
Actinomycosis is a chronic, slowly progressive, suppurative, and tissue-destructive infection characterized by mass-like lesions and sinus tract formation. It most commonly affects the head and neck region but may also involve the thorax, abdomen, pelvis, central nervous system, bones, and soft tissues. The disease is indolent and often mimics malignancy or other chronic infections.
The reported incidence is approximately 1 per 300,000 population in the United States and about 1 per 100,000 in Europe. It occurs at all ages, with peak frequency in middle-aged adults, and has a male-to-female ratio of about 3:1. Risk factors include poor oral hygiene, dental manipulation, oral trauma, intrauterine contraceptive device (especially when used for more than 2 years), abdominal surgery, appendicitis, diverticulitis, foreign bodies, malnutrition, and immunodeficiency such as HIV infection, chronic granulomatous disease, or prolonged corticosteroid therapy. Cases have also been described in osteoradionecrosis and bisphosphonate-related mandibular osteonecrosis. Prevention includes maintaining good oral hygiene and, in women with long-term intrauterine devices and suspicious symptoms, device removal with short-term antibiotic therapy. Patient isolation is not required.
Humans are the natural reservoir. The organisms colonize the oral cavity, particularly dental plaque and tonsillar crypts, as commensals. Infection typically follows disruption of the mucosal barrier due to trauma or surgery, allowing invasion into deeper tissues. The disease spreads contiguously and occasionally hematogenously. Aspiration may lead to thoracic involvement, while abdominal and pelvic disease often follows bowel perforation, appendicitis, or diverticulitis. Although incubation is unclear, diagnosis is usually delayed because of the chronic course. Clinical forms include cervicofacial, thoracic, abdominal, pelvic, central nervous system, and disseminated disease.
Actinomyces species are microaerophilic or anaerobic, filamentous, branched, Gram-positive, non–acid-fast rods. Actinomyces israelii is the most frequently identified species, although A. naeslundii, A. meyeri, A. odontolyticus, and Propionibacterium propionica have also been implicated. These organisms are normal flora of the oral cavity and female genital tract. Most infections are polymicrobial, often involving anaerobic oral flora that may act as copathogens.
Clinical presentation varies by site. Patients may have low-grade fever, weight loss, and pain. Cervicofacial disease often presents with perimandibular swelling, trismus, and purplish discoloration of overlying skin, with sinus tract formation draining characteristic yellow “sulfur granules.” Thoracic disease presents with cough, chest pain, dyspnea, mass-like lesions, pleural thickening, empyema, chest wall invasion, and possible mediastinal or spinal involvement. Abdominal disease typically manifests as a firm mass, often in the right iliac fossa following appendicitis, or in the left lower quadrant after diverticulitis, sometimes with chronic perianal abscesses and fistulae. Pelvic disease may present as abscesses or a “frozen pelvis.” Central nervous system involvement causes focal neurologic deficits or chronic meningitis.
Diagnosis requires high suspicion, especially when mass lesions coexist with draining sinuses and sulfur granules. Specimens should be obtained before antibiotic therapy. Gram stain of pus or tissue from sterile sites demonstrating filamentous, Gram-positive, non–acid-fast organisms is more sensitive than culture. Swab cultures are not recommended, and specimens must be processed anaerobically. Direct immunofluorescence may assist in specific cases. Imaging with CT or MRI helps determine disease extent. Lung disease may show the “open bronchus sign.” Bone involvement may demonstrate a saw-toothed appearance, and CNS disease often appears as single or multiloculated lesions with surrounding edema. Differential diagnosis includes malignancy, nocardiosis, tuberculosis, botryomycosis, and endemic fungal infections.
Treatment consists of prolonged high-dose penicillin therapy. Recommended first-line therapy includes intravenous penicillin G (10–24 million units daily in divided doses) for 2–6 weeks, followed by oral penicillin V for 6–12 months, or intravenous ampicillin followed by oral amoxicillin for similar duration. Mild cervicofacial disease may be treated with oral therapy alone. Alternatives for penicillin-allergic patients include tetracyclines, erythromycin, or clindamycin. Surgical intervention, including abscess drainage or excision of fibrotic tissue, is often necessary.
Prognosis is generally excellent with appropriate prolonged therapy, as resistance among Actinomyces species is rare. Treatment failure usually suggests an undrained abscess or presence of resistant copathogens. Potential complications include disseminated disease and bowel obstruction in extensive abdominal or pelvic involvement.
0 Comments
